Kabonk: Thanks for articulating a lot of my reactions to this PR. My first reaction was that they were "throwing us a bone" because they had built up expectations of great 700 mg top line results by Christmas and they were late again. But now after realizing that they have the placebo results and in a form that allows them to compare with the 350 mg open label trial, I'm disheartened. Shouldn't they also have the results from the 700 mg trial arm as well? Is it more difficult or time consuming to do the statistical analysis for that arm than the open label trial? This doesn't feel right to me. But WDIK. Ganesha